-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
MCoxsPHHKj6o63X5BrctBxjXqaoP2c8yzcQVWvtcgbcV5d8Z9cp260WZa4Z5lR9y
k5xEm67qNyJisw41rKnRzQ==
SECURITIES AND EXCHANGE COMMISSION SCHEDULE 13DA UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 4) Targeted Genetics Corporation Common Shares 876 12M 108 Ginette Depelteau April 01, 2003 If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. [ ] Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 240.13d-7(b) for other parties to whom copies are to be sent. * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). This Amendment No. 4, dated April 1, 2003 is being filed jointly on behalf of Caisse de dépôt et placement du Québec ("CDPQ") and its wholly-owned subsidiary, Capital Technologies CDPQ inc. ("Capital") pursuant to Rule 13d-2(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act") pursuant to a Joint Filing Agreement dated April 1, 2003, between CDPQ and Capital, a copy of which is attached hereto as Exhibit A. Item 1 - Security and Issuer This statement is made with respect to the Common Shares (the "Shares") of Targeted Genetics Corporation ("Targeted"), a Washington corporation (the "Company"). The address of the principal executive offices of which is 1100 Olive Way, Seattle, WA, 98101. Item 2 - Identity and Background This Schedule 13DA is filed jointly on behalf of CDPQ, a legal person without share capital and a mandatary of the State of the Province de Québec, created by a special act of the Legislature of the Province de Québec, and Capital, a legal entity duly incorporated under part 1A of the Companies ACT (Québec) and a wholly-owned subsidiary of CDPQ, pursuant to Rule 13d-1(f)(1) under the Exchange Act. The principal business address and the principal office address of each of CDPQ and Capital is 1000 place Jean-Paul Riopelle, Montréal, Québec, H2Z 2B3. The names, business addresses and principal occupation of each director and executive officer of CDPQ and Capital are set forth in Exhibit B, attached hereto. Each of the directors and executive officers named in Exhibit B is a Canadian citizen, except Mr. John T. Wall who is an American citizen. To the best knowledge of CDPQ and Capital, none of the persons listed on Exhibit B has, during the last five years, (i) been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors) or (ii) been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, United States federal or state securities laws or finding any violation with respect to such laws. Item 3 - Source and Amount of Funds or Other Consideration Capital sold 400,000 Shares for Can. $171,702. Item 4 - Purpose of Transaction Neither CDPQ nor Capital has any plans or proposals which relate to or would result in any of the actions or effects set forth in Item 5 of Schedule 13DA, although either of them may develop such plans or proposals. CDPQ and Capital intend to review on a continuing basis their investment in the Company. As of the date of this Schedule 13DA, no determination has been made by CDPQ or Capital to acquire additional shares of Common Stock or dispose of any shares of Common Stock now held by them, although either of them may decide to so acquire or dispose of shares of Common Stock. Any such determination will depend on market conditions prevailing from time to time and on other conditions which may be applicable depending on the nature of the transaction or transactions involved. Item 5 - Interest in Securities of Issuer Item 6 - Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer Except as set forth in this Schedule 13DA, there are no contracts, arrangements, understandings or relationships (legal or otherwise) among the persons referred to in Item 2 of this Schedule 13DA or between such persons and any other person with respect to any of the securities of the Company, including, but not limited to, any relating to the transfer or voting of any of such securities, finder's fees, joint ventures, loan or option arrangements, puts or calls, guarantees of profits, division of profits or loss or the giving or withholding of proxies. Item 7 - Material to be Filed as Exhibits Exhibit A: Joint Filing Agreement dated January 22, 2003 by and between Capital and CDPQ After reasonable inquiry and to the best of my knowledge and belief of the undersigned, the undersigned certifies that the information set forth in this statement is true, complete and correct. Signature Date: April 1, 2003 Capital Technologies CDPQ inc. Ginette Depelteau ----------------------------------------------------------------------- Ginette Depelteau, Corporate Secretary Caisse de dépot et placement du Québec Ginette Depelteau ----------------------------------------------------------------------- Ginette Depelteau, Vice-president and Corporate Secretary EXHIBIT A Agreement The undersigned hereby agree that this statement on Schedule 13D with respect to beneficial ownership of shares of common stock of Targeted Genetics Inc. is filed jointly, on behalf of each of them. Dated: April 1, 2003 Capital Technologies CDPQ inc. By: Denis Dionne By: Ginette Depelteau Caisse de dépot et placement du Québec By: Claude Bergeron By: Ginette Depelteau EXHIBIT B LIST OF EXECUTIVE OFFICERS AND DIRECTORS Capital Technologies CDPQ Inc. DIRECTORS BUSINESS ADDRESS PRINCIPAL OCCUPATION Henri-Paul Rousseau Caisse de dépôt et placement du Québec Chairman and Chief Jacques M. Brault Financière Banque Nationale General Manager Denis Dionne Capital Technologies CDPQ Inc. President Claude Lajeunesse Ryerson Polytechnic University President and Vice- Serge Martin Martin International President Guy Morneau Régie des rentes du Québec Chairman of the Board André Nadeau CGI Group Inc. Executive Vice-President Louis Brunel Institut International des President and Chief Khalil Barsoum 30 Valentine Drive
Washington, D.C. 20549
(Rule 13d-101)
(Name of Issuer)
(Title of Class of Securities)
(CUSIP Number)
Capital Technologies CDPQ inc.
(formely Sofinov, Société financière d'innovation inc.)
1000 place Jean-Paul-Riopelle, Montreal (Quebec), H2Z 2B3
Tel.: (514) 847-5901
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
(Date of Event which Requires Filing of this Statement)
I.R.S. Identification nos. of above persons (entities only)
Capital Technologies CDPQ inc. (formely Sofinov, Société financière d'innovation Inc.)
-------------------------------------------------------------------------------------------------------------
(a) [ ]
(b) [ ]
- -------------------------------------------------------------------------------------------------------------
- -------------------------------------------------------------------------------------------------------------
WC
-------------------------------------------------------------------------------------------------------------
- -------------------------------------------------------------------------------------------------------------
Montreal (Quebec) Canada
-------------------------------------------------------------------------------------------------------------
3,200,000 Common Shares (includes 1,333,333 Shares of Common Stock of the company issuable upon exercise of a Warrant. See Item 4)
-------------------------------------------------------------------------------------------------------------
- -------------------------------------------------------------------------------------------------------------
3,200,000 Common Shares
-------------------------------------------------------------------------------------------------------------
- -------------------------------------------------------------------------------------------------------------
3,200,000 Common Shares
-------------------------------------------------------------------------------------------------------------
(See Instructions) [ ]
- -------------------------------------------------------------------------------------------------------------
5.82%
-------------------------------------------------------------------------------------------------------------
CO
-------------------------------------------------------------------------------------------------------------
I.R.S. Identification nos. of above persons (entities only)
Caisse de dépôt et placement du Québec
-------------------------------------------------------------------------------------------------------------
(a) [ ]
(b) [ ]
- -------------------------------------------------------------------------------------------------------------
- -------------------------------------------------------------------------------------------------------------
WC
-------------------------------------------------------------------------------------------------------------
- -------------------------------------------------------------------------------------------------------------
Montreal (Quebec) Canada
-------------------------------------------------------------------------------------------------------------
3,200,000 Common Shares (includes 1,333,333 Shares of Common Stock of the company issuable upon exercise of a Warrant. See Item 4)
-------------------------------------------------------------------------------------------------------------
- -------------------------------------------------------------------------------------------------------------
3,200,000 Common Shares
-------------------------------------------------------------------------------------------------------------
- -------------------------------------------------------------------------------------------------------------
3,200,000 Common Shares
-------------------------------------------------------------------------------------------------------------
(See Instructions) [ ]
- -------------------------------------------------------------------------------------------------------------
5.82%
-------------------------------------------------------------------------------------------------------------
CO
-------------------------------------------------------------------------------------------------------------
Exhibit B: List of Executive Officers and Directors of Caisse de depot et placement du Québec and Capital Technologies CDPQ inc.
Exhibit C: Joint Filing Table of Dates, Number of Shares sold and price per Share of Sales
Signature
Name / Title
Signature
Name / Title
Name: Denis Dionne
Title: President
Name: Ginette Depelteau
Title: Corporate Secretary
Name: Claude Bergeron
Title: Vice-President, Legal Affairs
Name: Ginette Depelteau
Title: Vice-President and Corporate
Secretary
1981, avenue McGill College
Montréal (Québec) H3A 3C7
Executive Officer
1155, Metcalfe, 23e étage
Montréal (Québec) H3B 4S9
1981, avenue McGill College
Montréal (Québec) H3A 3C7
350, Victoria Street
Toronto (Ontario) H2M 2V1
Chancellor
500, Place d'Armes, Suite 2910
Montréal (Québec) H2Y 2W2
2600, boul. Laurier, bureau 546
Québec (Québec) G1V 4T3
and President
1130, Sherbrooke West, 5th Floor
Montreal (Quebec) H3A 2M8
and Chief Strategy Officer
Télécommunications
Place Bonaventure
800, de la Gauchetière Ouest,
Suite 6700
Montréal (Québec) H5A 1K6
Executive Office
Toronto (Ontario) M3A 3J8
OFFICERS |
BUSINESS ADDRESS |
PRINCIPAL OCCUPATION |
Henri-Paul Rousseau |
Caisse de dépôt et placement du Québec |
Chairman and Chief |
Denis Dionne |
Capital Technologies CDPQ Inc. |
President |
Ghislain Parent |
Caisse de dépôt et placement du Québec |
Vice-President, |
Ginette Depelteau |
Same |
Secretary |
LIST OF EXECUTIVE OFFICERS AND DIRECTORS
CAISSE DE DÉPÔT ET PLACEMENT DU QUÉBEC
DIRECTORS |
BUSINESS ADDRESS |
PRINCIPAL |
Henri-Paul Rousseau |
Caisse de dépôt et placement du Québec |
Chairman and Chief |
Guy Morneau |
Régie des rentes du Québec |
Chairman of the Board and President |
Jean-Claude Bachand |
Fraser Milner Casgrain |
Lawyer |
Bernard Bonin |
745, Hot Springs Way |
|
Claudette Carbonneau |
Confédération des syndicats nationaux |
President |
Alban D'Amours |
Mouvement des caisses Desjardins |
President |
Sylvie Dillard |
Fonds québécois de la recherche sur la nature et les technologies |
Member and President of the board and Chief Executive Officer |
Yves Filion |
Hydro-Québec Distribution |
President |
Gilles Godbout |
Ministère des Finances |
Deputy Minister, Finance, Economy and Research |
Thomas O. Hecht |
Technologies IBEX Inc. |
Chairman Emeritus |
Henri Massé |
Fédération des travailleurs et travailleuses du Québec |
President |
Nicole Trudeau |
Commission municipale du Québec |
Vice-President |
Duc Vu |
Commission administrative des régimes de retraite et d'assurances |
President |
John T. Wall |
6601, Radnor Road |
|
OFFICERS |
BUSINESS ADDRESS |
PRINCIPAL |
Henri-Paul Rousseau |
Caisse de dépôt et placement du Québec |
Chairman and Chief |
Fernand Perreault |
Same |
President, CDP Capital - |
Richard Guay |
Same |
Executive Vice-President, |
Ghislain Parent |
Same |
Executive Vice-President, |
François Geoffrion |
Same |
Executive Vice-President, |
Ginette Depelteau |
Same |
Vice-President and Corporate Secretary |
EXHIBIT C
TABLE OF PURCHASES AND SALES
OF TARGETED GENETICS CORPORATION
SALES
|
|
PRICE PER |
January February April |
|
|
Sales effected in United States